SB-612,111

SB-612,111 is a drug that acts as a potent and selective antagonist for the Orexin receptor. It has been used in scientific research to explore the role of the orexin system in regulation of the sleep-wake cycle, feeding behavior, and other physiological processes.

Pharmacology

SB-612,111 is a non-peptide antagonist of the Orexin receptor. It has a high affinity for both the OX1 and OX2 subtypes of the orexin receptor, with a slightly higher affinity for the OX1 subtype. The drug inhibits the binding of Orexin-A and Orexin-B to their respective receptors, thereby blocking the effects of these neuropeptides.

Uses

SB-612,111 has been used in scientific research to investigate the role of the orexin system in various physiological processes. It has been used in studies on the regulation of the sleep-wake cycle, feeding behavior, and other processes. The drug has also been used in research on the potential therapeutic applications of orexin receptor antagonists in conditions such as Insomnia, Narcolepsy, and Obesity.

Side Effects

As a research chemical, SB-612,111 is not intended for human consumption, and its safety profile in humans has not been established. In animal studies, the drug has been shown to cause sedation and to reduce food intake, consistent with its antagonistic effects on the orexin system.

See Also

• Orexin receptor
• Orexin-A
• Orexin-B
• Insomnia
• Narcolepsy
• Obesity

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia